Fully occupied premium medical co-working facility in Central London, generating £29,050 in monthly contracted income and approximately £200,000 annual EBITDA. With all 12 treatment rooms occupied, licence agreements extending to 2028 and minimal owner involvement, this established business offers an attractive opportunity to acquire a profitable, recurring-revenue healthcare workspace.
The business comprises 12 fully fitted treatment rooms serving independent doctors, aesthetic practitioners and wellness professionals. Approximately £200,000 has been invested in a high-specification fit-out, including premium soundproofing, bespoke finishes and quality fixtures. The facility generates annualised revenue of £348,600, representing 18% year-on-year growth, with an EBITDA margin of approximately 57%.
Situated in Central London, the facility benefits from demand for premium medical and healthcare workspace. All treatment rooms are occupied under licence agreements, with principal licensees committed to fixed terms extending to 2028. More than £360,000 of income is already contracted under signed agreements, with no arrears or business debt reported. Licence income is collected monthly in advance, providing predictable cash flow.
Further growth opportunities include contracted licence fee increases, 10% renewal mechanisms, agreed stepped increases and additional revenue from daily room hire. The business operates with straightforward management requirements and approximately two hours of owner involvement per week. The existing lease runs until February 2035, with potential to negotiate an extension subject to landlord approval.
A comprehensive, solicitor-tested due diligence pack is available to qualified buyers, supporting an efficient acquisition process. Full handover and transitional support are available.
Key Investment Highlights:
- Fully occupied facility with 12 fitted treatment rooms.
- £29,050 monthly contracted income.
- £348,600 annualised turnover, up 18% year on year.
- Approximately £200,000 annual EBITDA.
- Approximately 57% EBITDA margin.
- Approximately 29% annual EBITDAtopurchaseprice ratio.
- Indicative EBITDA payback period of approximately 3.5 years.
- Over £360,000 of contracted income under signed agreements.
- Principal licence agreements extending to 2028.
- Approximately £200,000 invested in premium fitout.
- Lease secured until February 2035.
- Approximately two hours of owner involvement weekly.
- No reported arrears or business debt.
- Furniture, fixtures and fittings included.
The asking price is £695,000, payable in full on completion. Cash buyers are preferred, with no buyer financing or deferred payment arrangements proposed as standard. Exceptional alternative offers may be considered at the seller's discretion. Proof of funds is required before access to the confidential data room.
A lease extension may be requested before completion, subject to landlord agreement and an increase in the purchase price. Additional landlord premiums would be payable separately.
Enquire today to receive further information about this established Central London medical co-working business and its contracted income, operational structure and acquisition terms.
